Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Franceschi

Neurology

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Neurology|February 1, 1981
Three primitive reflexes in normal adultsM Franceschi
Neurology|May 1, 1996
AAMIM Franceschi, N Canal
Neurology|September 26, 2001
Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRIM Bozzali, M Franceschi, A Falini, et al.
Neurology|August 9, 2006
The contribution of voxel-based morphometry in staging patients with mild cognitive impairmentM Bozzali, M Filippi, G Magnani, et al.
Neurology|November 24, 1999
APOE-491 promoter polymorphism is a risk factor for late-onset Alzheimer's diseaseV M Casadei, C Ferri, F Veglia, et al.
Neurology|September 10, 2009
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer diseaseAlberto Pilotto, M Franceschi, G D'Onofrio, et al.
Neurology|December 30, 2004
MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PETL Mosconi, D Perani, S Sorbi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Neurology|February 1, 1981
Three primitive reflexes in normal adultsM Franceschi
Neurology|May 1, 1996
AAMIM Franceschi, N Canal
Neurology|September 26, 2001
Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRIM Bozzali, M Franceschi, A Falini, et al.
Neurology|August 9, 2006
The contribution of voxel-based morphometry in staging patients with mild cognitive impairmentM Bozzali, M Filippi, G Magnani, et al.
Neurology|November 24, 1999
APOE-491 promoter polymorphism is a risk factor for late-onset Alzheimer's diseaseV M Casadei, C Ferri, F Veglia, et al.
Neurology|September 10, 2009
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer diseaseAlberto Pilotto, M Franceschi, G D'Onofrio, et al.
Neurology|December 30, 2004
MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PETL Mosconi, D Perani, S Sorbi, et al.
Pageof 1